The role of kidney transplantation and phosphate binder use in vitamin K status

Thijs T. Jansz, Aegida Neradova, Adriana J. van Ballegooijen, Marianne C. Verhaar, Marc G. Vervloet, Leon J. Schurgers, Brigit C. van Jaarsveld

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article numbere0203157
Number of pages13
JournalPLOS ONE
Volume13
Issue number8
DOIs
Publication statusPublished - 30 Aug 2018

Keywords

  • MATRIX GLA-PROTEIN
  • STAGE RENAL-DISEASE
  • HEMODIALYSIS-PATIENTS
  • VASCULAR CALCIFICATION
  • MORTALITY
  • COHORT
  • SUPPLEMENTATION
  • SEVELAMER
  • SURVIVAL
  • IMPACT
  • Prospective Studies
  • Cross-Sectional Studies
  • Humans
  • Middle Aged
  • Extracellular Matrix Proteins/blood
  • Chelating Agents/adverse effects
  • Male
  • Kidney Transplantation
  • Kidney Failure, Chronic/blood
  • Female
  • Sevelamer/adverse effects
  • Calcium-Binding Proteins/blood
  • Renal Dialysis
  • Vitamin K/antagonists & inhibitors

Cite this

Jansz, T. T., Neradova, A., van Ballegooijen, A. J., Verhaar, M. C., Vervloet, M. G., Schurgers, L. J., & van Jaarsveld, B. C. (2018). The role of kidney transplantation and phosphate binder use in vitamin K status. PLOS ONE, 13(8), [e0203157]. https://doi.org/10.1371/journal.pone.0203157